We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DNUT:NASDAQKrispy Kreme, Inc. Analysis

Data as of 2026-06-09 - not real-time

$3.70

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Krispy Kreme’s stock is trading at $3.70, well below its 20‑day, 50‑day and 200‑day moving averages, signaling a bearish technical backdrop. The RSI sits around 60, hinting at neutral‑to‑slightly‑overbought momentum, while the MACD histogram is positive, offering a modest bullish signal. Volatility is elevated at over 50% for the past 30 days and beta exceeds 1.1, indicating the share moves more aggressively than the market. Recent Q1 results showed a 2.2% revenue decline and a non‑GAAP loss of $0.05 per share, missing consensus, yet the stock rallied on the news. Fundamentally, the company posts negative operating and profit margins, a steep debt‑to‑equity ratio above 200%, and a negative ROE, while cash on hand is modest relative to debt. The dividend yield appears attractive at 3.5%, but the payout ratio is high and earnings are negative, raising sustainability concerns. Analyst consensus points to a mean target of $4.35, implying roughly 17% upside from current levels.
Given the juxtaposition of a defensive consumer sector, a cheap price‑to‑sales multiple, and a solid dividend, there is a case for a modest upside play, but the heavy debt load and earnings weakness temper enthusiasm. The short‑term outlook remains cautious, the medium‑term view leans toward a selective buy on valuation and dividend appeal, and the long‑term stance is to monitor debt reduction and earnings recovery before committing fully.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Recent earnings miss and revenue decline
  • Price below key moving averages indicating bearish bias
  • MACD bullish divergence offering limited upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst price targets suggest ~17% upside
  • Attractive dividend yield relative to peers
  • Low price‑to‑sales multiple providing value entry

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt‑to‑equity ratio and negative ROE
  • Uncertain earnings sustainability and dividend coverage
  • Defensive consumer sector offering resilience over time

Key Metrics & Analysis

Financial Health

Revenue Growth-2.20%
Profit Margin-33.36%
P/E Ratio69.3
ROE-58.15%
ROA-1.16%
Debt/Equity201.77
P/B Ratio1.0
Op. Cash Flow$74.9M
Free Cash Flow$22.4M

Technical Analysis

TrendBearish
RSI60.2
Support$3.10
Resistance$3.80
MA 20$3.36
MA 50$3.50
MA 200$3.62
MACDBullish
VolumeStable
Fear & Greed Index87.64

Valuation

Target Price$4.35
Upside/Downside17.57%
GradeFair
TypeValue
Dividend Yield3.47%

Risk Assessment

Beta1.13
Volatility54.00%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.